DK2206514T3 - Rekombinante intracellulære patogene immunogene sammensætninger og metoder til anvendelse - Google Patents

Rekombinante intracellulære patogene immunogene sammensætninger og metoder til anvendelse

Info

Publication number
DK2206514T3
DK2206514T3 DK10157659.3T DK10157659T DK2206514T3 DK 2206514 T3 DK2206514 T3 DK 2206514T3 DK 10157659 T DK10157659 T DK 10157659T DK 2206514 T3 DK2206514 T3 DK 2206514T3
Authority
DK
Denmark
Prior art keywords
methods
immunogenic compositions
intracellular pathogenic
recombinant intracellular
pathogenic immunogenic
Prior art date
Application number
DK10157659.3T
Other languages
English (en)
Inventor
Gunter Harth
Marcus A Horwitz
Michael V Tullius
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK2206514T3 publication Critical patent/DK2206514T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK10157659.3T 2003-10-16 2004-10-15 Rekombinante intracellulære patogene immunogene sammensætninger og metoder til anvendelse DK2206514T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51256503P 2003-10-16 2003-10-16
EP04795381A EP1684798A4 (en) 2003-10-16 2004-10-15 RECOMBINANT INTRA-CELLULAR PATHOGENIC IMMUNOGENIC COMPOSITIONS AND APPLICATION PROCEDURES

Publications (1)

Publication Number Publication Date
DK2206514T3 true DK2206514T3 (da) 2014-04-22

Family

ID=34465361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10157659.3T DK2206514T3 (da) 2003-10-16 2004-10-15 Rekombinante intracellulære patogene immunogene sammensætninger og metoder til anvendelse

Country Status (4)

Country Link
US (2) US7622107B2 (da)
EP (2) EP2206514B1 (da)
DK (1) DK2206514T3 (da)
WO (1) WO2005037222A2 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8287879B2 (en) 2003-10-16 2012-10-16 The Regents Of The University Of California Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
US8383132B2 (en) 2003-10-16 2013-02-26 The Regents Of The University Of California Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
DK2206514T3 (da) * 2003-10-16 2014-04-22 Univ California Rekombinante intracellulære patogene immunogene sammensætninger og metoder til anvendelse
US8163294B2 (en) 2003-10-16 2012-04-24 The Regents Of The University Of California Growth regulatable recombinant BCG compositions
EP1882741B1 (en) * 2006-07-25 2010-06-30 Institut Pasteur Recombinant Mycobacterium strain expressing a mycobacterial FAP protein under the control of a promoter active under hypoxia and its application for cancer therapy
WO2009045575A2 (en) * 2007-06-14 2009-04-09 The Regents Of The University Of California Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins
US7670609B2 (en) * 2007-11-27 2010-03-02 Aeras Global Tb Vaccine Foundation Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease
US8361482B2 (en) * 2007-11-27 2013-01-29 Aeras Global Tb Vaccine Foundation Recombinant BCG tuberculosis vaccine designed to elicit immune responses to mycobacterium tuberculosis in all physiological stages of infection and disease
WO2016157200A1 (en) * 2015-04-03 2016-10-06 Foschneano Gido Means and method for salt roasting of food
WO2018026729A1 (en) 2016-08-01 2018-02-08 The Regents Of The University Of California Safe potent single platform vaccine against tier 1 select agents and other pathogens
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN113999865B (zh) * 2021-10-09 2023-06-16 安徽理工大学 结核分枝杆菌融合蛋白ar2及其构建与表达纯化方法和应用
CN115725546A (zh) * 2022-10-13 2023-03-03 湖南大学 具有激活植物免疫功能的α-甘露糖苷酶及应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591632A (en) * 1987-03-02 1997-01-07 Beth Israel Hospital Recombinant BCG
JP3011939B2 (ja) 1987-03-02 2000-02-21 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ 組換えミコバクテリア・ワクチン
US5807723A (en) * 1987-03-02 1998-09-15 Whitehead Institute For Biomedical Research Homologously recombinant slow growing mycobacteria and uses therefor
US5504005A (en) 1987-03-02 1996-04-02 Albert Einstein College Of Medicine Of Yeshiva University Recombinant mycobacterial vaccine
JP2903414B2 (ja) * 1989-05-31 1999-06-07 味の素株式会社 抗酸菌分泌発現ベクター及び抗酸菌
WO1993007897A1 (en) * 1991-10-21 1993-04-29 Medimmune, Inc. Bacterial expression vectors containing dna encoding secretion signals of lipoproteins
US5736367A (en) * 1992-03-31 1998-04-07 Medimmune, Inc. Vectors and prokaryotes which autocatalytically delete antibiotic resistance
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
US6599510B1 (en) 1993-11-23 2003-07-29 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US5679515A (en) * 1994-10-03 1997-10-21 Pathogenesis Corporation Mycobacterial reporter strains and uses thereof
US5700683A (en) * 1995-02-17 1997-12-23 Pathogenesis Corporation Virulence-attenuating genetic deletions deleted from mycobacterium BCG
US5869057A (en) * 1995-06-07 1999-02-09 Rock; Edwin P. Recombinant vaccines to break self-tolerance
CA2278116A1 (en) * 1997-01-21 1998-07-23 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US6471967B1 (en) * 2000-04-17 2002-10-29 The Regents Of The University Of California Recombinant intracellular pathogen vaccines and methods for use
US6924118B2 (en) * 2000-04-17 2005-08-02 The Regents Of The University Of California Recombinant intracellular pathogen immunogenic compositions and methods for use
DE10026752A1 (de) 2000-05-30 2001-12-06 Kloeckner Humboldt Wedag Gleitschuhlagerung für Drehtrommeln wie z.B. Rohrmühlen
EP1164488A1 (en) 2000-06-14 2001-12-19 Canal+ Technologies Société Anonyme Remote debugging in an embedded system enviroment
GB0014845D0 (en) * 2000-06-16 2000-08-09 Glaxo Group Ltd Vaccine
US7288261B2 (en) * 2000-07-10 2007-10-30 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
US7722861B2 (en) * 2002-02-19 2010-05-25 Svetoslav Bardarov, legal representative Attenuated Mycobacterium tuberculosis vaccines
DK2206514T3 (da) * 2003-10-16 2014-04-22 Univ California Rekombinante intracellulære patogene immunogene sammensætninger og metoder til anvendelse

Also Published As

Publication number Publication date
EP1684798A2 (en) 2006-08-02
US20070128216A1 (en) 2007-06-07
EP2206514A3 (en) 2010-12-08
WO2005037222A2 (en) 2005-04-28
WO2005037222A3 (en) 2005-09-09
US7622107B2 (en) 2009-11-24
EP2206514A2 (en) 2010-07-14
EP2206514B1 (en) 2014-01-08
US8124068B2 (en) 2012-02-28
EP1684798A4 (en) 2007-12-05
US20100092518A1 (en) 2010-04-15

Similar Documents

Publication Publication Date Title
DK1948695T3 (da) Immunogene sammensætninger og fremgangsmåder til andvendelse
DE60313163D1 (de) Immunogene zusammensetzungen
IS7966A (is) Pyrazól og aðferðir við að búa þau til og notkun þeirra
ZA200806863B (en) Disruptions of genes encoding secreted proteins, compositions and methods relating thereto
DK3366283T3 (da) Direkte sammenpresningsformulering og fremgangsmåde
DK3524657T3 (da) Sammensætninger omfattende hfc-1234yf og hfc-32
DE602004024731D1 (de) Tonerzusammensetzungen und Herstellungsverfahren
MA28994B1 (fr) Composition immunogene
DK1638999T3 (da) Sammensætninger og fremgangsmåder til øgning af knoglemineralisering
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
IS7977A (is) Samsetningar og aðferð til samsettra meðferðar
DK1539224T3 (da) Antimikrobielt præparat og fremgangsmåde til anvendelse
DK2952178T3 (da) Oftalmiske sammensætninger og fremgangsmåder til behandling af øjne
NO20054765D0 (no) Nye probiotiske sammensetninger og fremgangsmater for anvendelse derav
DK1594867T3 (da) Phenylacetamider og deres anvendelse som glucokinasemodulatorer
DK1673460T3 (da) Rekombinante vacciner og anvendelse af disse
DK1753387T3 (da) Kosmetiske sammensætninger af kaffebær og fremgangsmåder
DK1713544T3 (da) Sammensætninger og fremgangsmåder til oral og personlig pleje
IS8597A (is) Samsetningar rísedrónats og aðferðir við notkun þess
DK1701946T3 (da) 1-piperazin- og 1-homopiperazincarboxylatderivater, deres fremstilling og deres terapeutiske anvendelse som inhibitorer af FAAH-enzymet
DK2206514T3 (da) Rekombinante intracellulære patogene immunogene sammensætninger og metoder til anvendelse
DK1537096T3 (da) Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
DK1503726T3 (da) Antibakterielt tandpræparat med antiplak og åndeopfriskende egenskaber
DK1590321T3 (da) Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
DK1478438T3 (da) Fremgangsmåder og sammensætninger til behandling af astma